A detailed history of Mbm Wealth Consultants, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mbm Wealth Consultants, LLC holds 11,263 shares of ABBV stock, worth $2.27 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
11,263
Previous 11,396 1.17%
Holding current value
$2.27 Million
Previous $1.95 Million 13.82%
% of portfolio
0.72%
Previous 0.67%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$163.84 - $199.33 $21,790 - $26,510
-133 Reduced 1.17%
11,263 $2.22 Million
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $25,230 - $29,463
163 Added 1.45%
11,396 $1.95 Million
Q1 2024

Apr 18, 2024

SELL
$159.82 - $182.1 $10,867 - $12,382
-68 Reduced 0.6%
11,233 $2.05 Million
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $22,704 - $25,570
-165 Reduced 1.44%
11,301 $1.75 Million
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $14,427 - $16,702
108 Added 0.95%
11,466 $1.71 Million
Q2 2023

Jul 24, 2023

BUY
$132.51 - $164.9 $97,659 - $121,531
737 Added 6.94%
11,358 $1.53 Million
Q4 2022

Feb 15, 2023

BUY
$138.31 - $165.87 $13,001 - $15,591
94 Added 0.89%
10,621 $1.73 Million
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $63,347 - $72,654
472 Added 4.69%
10,527 $1.46 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $40,873 - $51,963
-297 Reduced 2.87%
10,055 $1.54 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $2,639 - $3,275
20 Added 0.19%
10,352 $1.68 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $1,933 - $2,446
18 Added 0.17%
10,332 $1.4 Million
Q3 2021

Nov 16, 2021

SELL
$106.4 - $120.78 $1,489 - $1,690
-14 Reduced 0.14%
10,314 $1.11 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $3,577 - $3,985
-34 Reduced 0.33%
10,328 $1.16 Million
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $49,922 - $54,958
-488 Reduced 4.5%
10,362 $1.12 Million
Q4 2020

Feb 09, 2021

SELL
$80.49 - $108.67 $2,978 - $4,020
-37 Reduced 0.34%
10,850 $1.16 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $10,910 - $12,805
-127 Reduced 1.15%
10,887 $953,000
Q2 2020

Aug 07, 2020

SELL
$73.37 - $98.18 $351,222 - $469,987
-4,787 Reduced 30.3%
11,014 $1.08 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $10,126 - $15,353
-157 Reduced 0.98%
15,801 $1.25 Million
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $95,644 - $119,671
-1,326 Reduced 7.67%
15,958 $1.41 Million
Q3 2019

Oct 30, 2019

BUY
$62.98 - $75.72 $12,218 - $14,689
194 Added 1.14%
17,284 $1.31 Million
Q2 2019

Jul 30, 2019

BUY
$65.7 - $83.98 $27,199 - $34,767
414 Added 2.48%
17,090 $1.26 Million
Q1 2019

Apr 25, 2019

BUY
$77.14 - $90.79 $26,381 - $31,050
342 Added 2.09%
16,676 $1.34 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $1.27 Million - $1.57 Million
16,334 New
16,334 $1.51 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mbm Wealth Consultants, LLC Portfolio

Follow Mbm Wealth Consultants, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mbm Wealth Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mbm Wealth Consultants, LLC with notifications on news.